Nevro receives approval for spinal cord stimulation system to treat chronic pain

Written by Alan Condon | November 06, 2019 | Print  |

Nevro received FDA approval for Senza Omnia device, its new spinal cord stimulation system.

Four insights:

1. Senza Omnia delivers Nevro's HF10 therapy as well as other spinal cord stimulation frequencies.

2. It features a programmer that facilitates more waveforms across the spinal cord frequency spectrum.

3. Senza Omnia has a redesigned patient remote, which aims to enhance the patient experience.

4. It also features an updated implantable pulse generator that is designed to last 10 years no matter what simulation profile is used.

More articles on devices:
Dr. Sergiy Nesterenko opens spine clinic in Texas
California hospital adds 7 neurosurgeons to curb patient leakage
Drs. Nic Gay, Kerisimasi Reynolds team to form Silicon Valley Orthopaedics

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers